The RPC Proton Therapy Approval Process

Slides:



Advertisements
Similar presentations
WI State Report RVIPP, Indianapolis, IN June 9-10, 2010.
Advertisements

Harvard Medical School Massachusetts General Hospital.
RapidArc plan verification using ArcCHECK™
Commissioning an Anthropomorphic Spine and Lung Phantom for Remote Dose Verification of Institutions Participating in RTOG 0631 Douglas Caruthers, M.S.;
Experience, Expertise and a Commitment to Excellence™
FDA-QA-DAS/2010 FDA’s Public Meeting: Device Improvements to Reduce the Number of Under-doses, Over-doses, and Misaligned Exposures from Therapeutic Radiation.
Challenges in Credentialing Institutions and Participants in Advanced Technology Clinical Trials Geoffrey Ibbott, David Followill, Andrea Molineu, Jessica.
Algorithms used in heterogeneous dose calculations show systematic error as measured with the Radiological Physics Center’s anthropomorphic thorax phantom.
Research Protocol ACRIN 6678 Learning About PET/CT Scans: Can PET/CT scans provide helpful information for the treatment of non-small cell lung cancer?
Targeting Issues For Proton Treatments Of The Prostate SJ Rosenthal Ph.D., JA Wolfgang Ph.D., Sashi Kollipara Department of Radiation Oncology Massachusetts.
Tumour Therapy with Particle Beams Claus Grupen University of Siegen, Germany [physics/ ] Phy 224B Chapter 20: Applications of Nuclear Physics 24.
Quality Assurance: Manufacturer & Clinical Aspects  Alan Cohen, M.S. DABR  Paul Naine, MSc. MIPEM  Jim Schewe, PhD, DABMP Accuray Incorporated Elekta.
Innovation/Impact: By designing a simulated human shaped (anthropomorphic) plastic phantom with targets, organs at risk (OAR) and heterogeneities, the.
CBER Irradiated Blood Components Jennifer Jones Consumer Safety Officer CBER, OBRR, DBA September 16, 2009.
Design and Scheduling of Proton Therapy Treatment Centers Stuart Price, University of Maryland Bruce Golden, University of Maryland Edward Wasil, American.
Radiotherapy Planning for Esophageal Cancers Parag Sanghvi, MD, MSPH 9/12/07 Esophageal Cancer Tumor Board Part 1.
Radiotherapy for Kidney cancer
Volumetric Multimodality Imaging and Planning Data: A Challenge for Cooperative Group Clinical Trials James A. Purdy, Ph.D. Professor and Director Division.
Dose Distribution and Scatter Analysis
Results The measured-to-predicted dose ratio criteria used by the RPC to credential institutions is , however for this work, a criteria of
11. – , Athens 8th European Conference on Medical Physics DOSIMETRY AUDITS IN RADIOTHERAPY IN THE CZECH REPUBLIC Irena Koniarová Daniela Ekendahl.
What Happens in the days before treatment ?
Simulating Potential Layouts for a Proton Therapy Treatment Center Stuart Price-University of Maryland Bruce Golden- University of Maryland Edward Wasil-
TWO FIELD BREAST PLAN VS. OPTIMIZED CONFORMAL BREAST PLAN: COMPARISON OF PLAN PARAMETERS Authors: Borko Basarić, Ozren Čudić, Milan Teodorović, Borislava.
CALGB Informational Session June 22, 2007 David Hurd, MD Interim Chair Data Audit Committee.
Heavy Ion Tumor Therapy
Quality Control in Radiation Therapy, A New Concept: Dosimetry Check
External Beam Radiation Therapy Special Procedures
Научно-практический центр протонной лучевой терапии и радиохирургии (Москва-Дубна) A SYSTEM FOR MEASUREMENT OF A THERAPEUTIC PROTON BEAM DOSE DISTRIBUTION.
MRI Guided Radiation Therapy: Brachytherapy
Patient Plan Results: Table 3 shows the ratio of the Pinnacle TPS calculation to the DPM recalculation for the mean dose from selected regions of interest.
David Followill, Ph.D. Radiological Physics Center
In vivo dosimetry Eirik Malinen Eva Stabell Bergstrand Dag Rune Olsen.
Comparison of Clinical Parameters for Proton Therapy in the United States Paige Summers, MS.
DICOM Anniversary Conference Experience Using DICOM-RT Objects for Clinical Trials QA Walter R. Bosch, D.Sc., John W. Matthews, D.Sc., Vincent A. Frouhar,
FDA Public Meeting: Device Improvements to Reduce the Number of Under-doses and Misaligned Exposures from Therapeutic Radiation.
Institute for Advanced Radiation Oncology
Medical Accelerator F. Foppiano, M.G. Pia, M. Piergentili
Radiological Physics Center David Followill, Ph.D. and RPC Staff.
Scanner Validation via the SNM Clinical Trials Network Phantom Program Paul E. Christian Molecular Imaging Program Huntsman Cancer Institute University.
The Radiological Physics Center’s Anthropomorphic Quality Assurance Phantom Program Carrie F. Amador, Nadia Hernandez, Andrea Molineu, Paola Alvarez, and.
1 A Comprehensive Study on the Heterogeneity Dose Calculation Accuracy in IMRT using an Anthropomorphic Thorax Phantom S Davidson 1, R Popple 2, G Ibbott.
Investigation of 3D Dosimetry for an Anthropomorphic Spine Phantom R. Grant 1,2, G. Ibbott 1, J. Yang 1, J. Adamovics 3, D Followill 1 (1)M.D. Anderson.
Development and Implementation of a Remote Audit Tool for High Dose Rate (HDR) 192 Ir Brachytherapy Using Optically Stimulated Luminescence Dosimetry Kevin.
Physics of carbon ions and principles of beam scanning G. Kraft Biophysik, GSI, Darmstadt, Germany PTCOG43 Educational Satellite Meeting: Principles of.
Introduction The Radiological Physics Center (RPC) anthropomorphic quality assurance (QA) phantom program is one tool the RPC uses to remotely audit institutions.
A Comparison Between Two Leading Stereotactic Platforms in the Treatment of Multiple Metastases Sandra Vermeulen MD, James Raisis.
Introduction to Radiation Therapy
TLD POSTAL DOSE QUALITY AUDIT FOR 6MV AND 15MV PHOTON BEAMS IN RADIOTHERAPY CLINICAL PRACTICE Sonja Petkovska 1, Margarita Ginovska 2, Hristina Spasevska.
Radiation Therapy Trials - Quality Assurance:  patient safety  adherence to protocol constraints  uniformity of patient treatments  efficient review.
Adapting A Clinical Medical Accelerator For Primary Standard Dosimetry
Development of elements of 3D planning program for radiotherapy Graphical editor options  automated enclose of contour  correction of intersections 
E. Mezzenga 1, E. Cagni 1, A. Botti 1, M. Orlandi 1, W.D. Renner 2, M. Iori 1 1. Medical Physics Unit, ASMN-IRCCS of Reggio Emilia, Italy 2. MathResolution.
Qing Liang, PhD Medical Physicist Mercy Health System, Janesville, WI
Retroactive Calculation of TLD and Film Dose in Anthropomorphic Phantom as Assessment of Updated TPS Performance H. Alkhatib 1, S. Oves 1, B. Tsang 1,
Treatment Chart Record of patients radiation therapy history. Must contain: History and diagnosis Rationale for treatment Treatment plan Consent Documentation.
Fracture Liaison Service Database
Management of independent motion between multiple targets in lung cancer radiation therapy  Feng Liu, PhD, An Tai, PhD, Ergun Ahunbay, PhD, Elizabeth.
IAEA E-learning Program
The magnitude of H&N IMRT dose delivery errors from three possible failure modes: beam quality, symmetry, and MLC position Jackie Tonigan, M.S. Advisor:
EURADOS Working Group 9: Radiation Dosimetry in Radiotherapy
INTRODUCTION RESULTS DATA ANALYSIS DISCUSSION METHODS REFERENCES
Left Posterior Superior Right Anterior Inferior
A. Nisbet 1,2, A. Dimitriadis 1,2,3, A.L. Palmer 1,4, C.H. Clark 2,3
Learning About PET/CT Scans:
Implementation of Object Spot Avoidance in Proton Pencil Beam Treatment on Whole Breast with Implant Metal Injector Peng Wang, PhD, DABR, Karla Leach,
Dose-Length Product to Effective Dose Conversion Factors for Common Computed Tomography Examinations Based on Canadian Clinical Experience  Idris A. Elbakri,
Introduction: My name is _____________ with InBalance.
GHG meeting at ESTRO36 May, 2017
SBRT trial QA IROC GHG meeting at ESTRO May, 2017
Presentation transcript:

The RPC Proton Therapy Approval Process Welcome to the RPC. Paige Summers, MS This project is supported by the Federal Share of program income earned by Massachusetts General Hospital on C06 CA059267, Proton Therapy Research and Treatment Center and by grants CA10953 and CA81647 (NCI, DHHS)..

RPC’s Proton Involvement Asked by the NCI to help ensure cooperative groups that proton centers are delivering clinically comparable and consistent dose Proton visits funded in part by NCI/MGH shared funds 10 clinical sites (8 in trials) Forecast 18 new sites NCI/MGH funds extended until 12/31/12

Proton Approval Steps Proton facility questionnaire Annual monitoring of beam calibrations by the RPC Ability to electronically transfer treatment plans Successful irradiation of RPC’s baseline proton phantoms Successful completion of on-site dosimetry review visit

Facility Questionnaire AAPM Proton Advisory group aids RPC in updating proton facility questionnaire Questions covered: Experiences in the clinic Dose calibration & verification Proton beam production & delivery Treatment Planning Immobilization Patient Alignment QA

Annual Beam Audit – RPC TLD Ten proton centers monitored In process of switching from TLD to OSLD to monitor beam output annually Plan to use dosimeters for depth dose measurements p⁺

Electronic Data Transfer Institutions must be able to submit treatment plans electronically to the ITC Data used for RPC phantom audits, study group credentialing

RPC Proton Phantom Program Baseline phantoms: Scattered, uniform scanning: prostate & spine Spot scanning: Lung, head, prostate

RPC Proton Site Visits NCI/RPC recommend institutions only visited after center has been routinely treating patients for minimum of 6 months with no fewer than 3 disease sites Different delivery modalities have separate audit requirements – must each be reviewed Prioritization dependent on inst. initiative, membership in cooperative groups, readiness Dosimetric and imaging quality evaluation criteria being developed

RPC Proton Site Visits Typical review components: Dosimetry equipment calibration CT scanner, CTN/RSP conversion Patient immobilization Treatment planning procedures QA documentation

RPC Proton Site Visits Typical site visit measurements Beam calibration comparison – RPC/Inst CAX lateral and depth dose profiles for reference and patient fields Scanning beam – less fields tested, more profiles obtained X-ray system measurements TLD measurements

RPC Proton Site Visits After visits, RPC generates comprehensive site visit report – sent to institution with recommendations If measurements and procedures pass criteria, approval letter sent to institution, ITC, RTOG, & QARC

Questions? http://www.mdanderson.org/patient-and-cancer-information/proton-therapy-center/meet-our-survivors/index.html

RPC Proton Phantom Program Goals: Implement use of OSLD for phantom audits Modify existing phantoms for proton use Liver: multiple targets Lung: motion Prostate: proton equivalent Head: H&N target Proton liver insert – blue water replaces polystyrene

RPC’s Proton Goals Proton facility questionnaire Have existing facilities update Set up facility questionnaire online OSLD for phantom audits Adapt site visit procedures for new proton technologies Scanning beams, MevIon systems

Most measurements at mid-SOBP ± 2 cm RPC Proton TLD Program Most measurements at mid-SOBP ± 2 cm 15

MR image fused with CT for prescription and dose calc Brain Phantom Selected Phantom Lab “Alderson” phantom Materials fall on CT#-RLSP curve Contains realistic bony anatomy Inserts with target and dosimetry will be constructed MR image to define CTV MR image fused with CT for prescription and dose calc 16

Lung Phantom 17